CLPT vs. MA
CLPT (ClearPoint Neuro, Inc.) and MA (Mastercard Incorporated) are both stocks. CLPT operates in Medical Devices (Healthcare), while MA operates in Credit Services (Financial Services). Over the past 5 years, CLPT returned -2.27%/yr vs 5.85%/yr for MA. At a 0.26 correlation, their price movements are largely independent.
Performance
CLPT vs. MA - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, CLPT achieves a 24.71% return, which is significantly higher than MA's -14.93% return.
CLPT
- 1D
- -4.00%
- 1M
- 49.13%
- YTD
- 24.71%
- 6M
- 16.77%
- 1Y
- 51.51%
- 3Y*
- 37.52%
- 5Y*
- -2.27%
- 10Y*
- —
MA
- 1D
- -1.16%
- 1M
- -2.90%
- YTD
- -14.93%
- 6M
- -15.64%
- 1Y
- -8.63%
- 3Y*
- 9.06%
- 5Y*
- 5.85%
- 10Y*
- 18.83%
CLPT vs. MA - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|---|
CLPT ClearPoint Neuro, Inc. | 24.71% | -11.05% | 126.51% | -19.83% | -24.51% | -29.39% | 200.95% |
MA Mastercard Incorporated | -14.93% | 9.04% | 24.17% | 23.40% | -2.66% | 1.16% | 8.30% |
Correlation
The correlation between CLPT and MA is 0.07, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.07 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.21 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.29 |
Correlation (All Time) Calculated using the full available price history since Feb 12, 2020 | 0.26 |
The correlation between CLPT and MA shifts across timeframes, from 0.07 (1 year) to 0.29 (5 years), reflecting how their relationship changes across market environments.
Fundamentals
CLPT:
$504.07M
MA:
$432.29B
CLPT:
-$1.01
MA:
$17.28
CLPT:
12.03
MA:
12.86
CLPT:
26.75
MA:
64.31
CLPT:
$40.61M
MA:
$33.94B
CLPT:
$25.32M
MA:
$26.70B
CLPT:
-$25.05M
MA:
$21.23B
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
CLPT vs. MA — Risk / Return Rank
CLPT
MA
CLPT vs. MA - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for ClearPoint Neuro, Inc. (CLPT) and Mastercard Incorporated (MA). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| CLPT | MA | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +0.90 | ||
| Sortino ratioReturn per unit of downside risk | +2.02 | ||
| Omega ratioGain probability vs. loss probability | 1.20 | 0.95 | +0.25 |
| Calmar ratioReturn relative to maximum drawdown | 0.73 | -0.41 | +1.15 |
| Martin ratioReturn relative to average drawdown | 1.13 | -0.82 | +1.95 |
Loading charts...
Drawdowns
CLPT vs. MA - Drawdown Comparison
The maximum CLPT drawdown since its inception was -84.62%, which is greater than MA's maximum drawdown of -62.67%. Use the drawdown chart below to compare losses from any high point for CLPT and MA.
Loading charts...
Drawdown Indicators
| CLPT | MA | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -84.62% | -62.67% | -21.95% |
Max Drawdown (1Y)Largest decline over 1 year | -70.74% | -20.91% | -49.83% |
Max Drawdown (3Y)Largest decline over 3 years | -70.74% | -20.91% | -49.83% |
Max Drawdown (5Y)Largest decline over 5 years | -79.96% | -28.25% | -51.71% |
Max Drawdown (10Y)Largest decline over 10 years | — | -41.00% | — |
Current DrawdownCurrent decline from peak | -42.36% | -18.81% | -23.55% |
Average DrawdownAverage peak-to-trough decline | -53.50% | -9.83% | -43.67% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 45.63% | 10.58% | +35.05% |
Volatility
CLPT vs. MA - Volatility Comparison
ClearPoint Neuro, Inc. (CLPT) has a higher volatility of 29.74% compared to Mastercard Incorporated (MA) at 6.56%. This indicates that CLPT's price experiences larger fluctuations and is considered to be riskier than MA based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| CLPT | MA | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 29.74% | 6.56% | +23.18% |
Volatility (6M)Calculated over the trailing 6-month period | 65.67% | 17.09% | +48.58% |
Volatility (1Y)Calculated over the trailing 1-year period | 104.26% | 21.39% | +82.87% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 78.80% | 24.04% | +54.76% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 80.77% | 26.94% | +53.83% |
Dividends
CLPT vs. MA - Dividend Comparison
CLPT has not paid dividends to shareholders, while MA's dividend yield for the trailing twelve months is around 0.67%.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
CLPT ClearPoint Neuro, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
MA Mastercard Incorporated | 0.67% | 0.53% | 0.50% | 0.53% | 0.56% | 0.49% | 0.45% | 0.44% | 0.53% | 0.58% | 0.74% | 0.66% |
Financials
CLPT vs. MA - Financials Comparison
This section allows you to compare key financial metrics between ClearPoint Neuro, Inc. and Mastercard Incorporated. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
CLPT vs. MA - Profitability Comparison
CLPT - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, ClearPoint Neuro, Inc. reported a gross profit of 7.76M and revenue of 12.13M. Therefore, the gross margin over that period was 64.0%.
MA - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Mastercard Incorporated reported a gross profit of 4.91B and revenue of 8.40B. Therefore, the gross margin over that period was 58.4%.
CLPT - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, ClearPoint Neuro, Inc. reported an operating income of -8.48M and revenue of 12.13M, resulting in an operating margin of -69.9%.
MA - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Mastercard Incorporated reported an operating income of 4.91B and revenue of 8.40B, resulting in an operating margin of 58.4%.
CLPT - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, ClearPoint Neuro, Inc. reported a net income of -9.55M and revenue of 12.13M, resulting in a net margin of -78.8%.
MA - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Mastercard Incorporated reported a net income of 3.88B and revenue of 8.40B, resulting in a net margin of 46.2%.
Frequently Asked Questions
CLPT and MA have a correlation of 0.07, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
CLPT has higher volatility (29.74%) compared to MA (6.56%). In terms of maximum drawdown, CLPT dropped -84.62% vs MA's -62.67%.
CLPT currently has the higher Sharpe Ratio (0.50 vs -0.41), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for CLPT and MA
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer